Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 14, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer

NEWARK, Calif., Nov. 14, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, today...
November 05, 2013 16:05 ET | Source: StemCells, Inc.

StemCells, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update

NEWARK, Calif., Nov. 5, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
October 31, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Webcast to Discuss Third Quarter 2013 Financial Results and Business Update

NEWARK, Calif., Oct. 31, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
October 29, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio

NEWARK, Calif., Oct. 29, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the acquisition of a portfolio of issued US and Canadian patents to which it had previously held an...
October 22, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Present at Leading Conference on Neuroregeneration in Barcelona

NEWARK, Calif., Oct. 22, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), the leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
October 21, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Results of Long-Term Follow-Up Study in Batten Disease

NEWARK, Calif., Oct. 21, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the results of a four-year observation study in patients with neuronal ceroid lipofuscinosis (NCL), also...
October 17, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Investigators From Two Clinical Trials to Present at Congress of Neurological Surgeons Annual Meeting

NEWARK, Calif., Oct. 17, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), the leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
October 10, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Executive Vice President Ann Tsukamoto, Ph.D., to Make Keynote Address at 2013 Stem Cell Meeting on the Mesa's Scientific Symposium

NEWARK, Calif., Oct. 10, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), the leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
October 09, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Present at 2013 Stem Cell Meeting on the Mesa's Regen Med Partnering Forum

NEWARK, Calif., Oct. 9, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), the leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
October 08, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Closing of $18.6 Million Public Offering

NEWARK, Calif., Oct. 8, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it has closed its previously announced underwritten public offering of common stock and warrants....